News / Health

    Measles Virus Proves Deadly Against Cancer

    Stacy Erholtz receives a test to confirm she's in remission from myeloma after receiving a novel virotherapy in this screenshot from a Mayo Clinic video.
    Stacy Erholtz receives a test to confirm she's in remission from myeloma after receiving a novel virotherapy in this screenshot from a Mayo Clinic video.

    Related Articles

    Video Could Existing Drugs Be Used to Treat Deadly MERS Virus?

    In lab studies, drugs against cancer, neurological disorders and other ailments show promise to help treat respiratory ailment

    New Treatment Regenerates Muscle Lost in Traumatic Injury

    Researchers say implanting material from a pig's bladder at the wound site enticed the patient's own stem cells to become muscle cells and regenerate tissue that had been lost
    A new study has, for the first time, demonstrated that a specific kind of virotherapy can infect and kill cancer in humans, leaving healthy cells unharmed.
     
    The study, conducted by the Mayo Clinic in Minnesota, involved just two patients, both of whom received a “single intravenous dose of an engineered measles virus (MV-NIS) that is selectively toxic to myeloma plasma cells," researchers said.
     
    Multiple myeloma affects the plasma cells in the bone marrow and causes skeletal or soft tissue tumors. It is rarely cured.
     
    The therapy brought about a complete remission in one of the patients, while only improving the second patient.
     
    “This is the first study to establish the feasibility of systemic oncolytic virotherapy for disseminated cancer,” said Dr. Stephen Russell, a Mayo Clinic hematologist, and first author of the paper and co-developer of the therapy in a statement. “These patients were not responsive to other therapies and had experienced several recurrences of their disease.”
     
    In an interview with VOA, Russell called viruses “the last untapped bioresource as destructive bioagents against cancer.”
     
    The two patients in the trial were given enough measles virus to vaccinate 100 million people. In a video about the treatment, Mayo doctors say the modified measles virus makes cancer cells join together and “essentially explode.”
     
    The therapy also may boost the patient’s immune system, allowing it to “mop up” any remaining cancer, they said.
     
    Using re-engineered viruses to fight cancer, also known as oncolytic virotherapy, is nothing new, dating back to the 1950s, according to the Mayo Clinic. But, according to researches, this study provides the “first well documented case of a patient with disseminated cancer having a complete remission at all disease sites after virus administration.”
     
    Good results with this kind of therapy have been seen with rodents, but this is the first time success has been reported in a human being. However, remission was only achieved in one of the two patients.

    Mixed results for patients
     
    The other patient did not respond as well. Nonetheless, by using a sophisticated imaging technique, doctors were able to tell that the virus had targeted cancerous cells.
     
    Russell said he and his colleagues found the difference in reaction between the two patients “puzzling,” but had some theories about why.
     
    He said the patient who’d gone into remission had less myeloma in her body and that the second patient’s cancer was in a “very advanced state” with “massive tumors in the legs and abdomen.”
     
    Another theory was that the second patient had more tumors in the muscles.
     
    “If we’d treated her earlier, we’d have done better, Russell said, adding that they might also have seen better results at a higher dose.
     
    There were negative side effects, he said, such as severe flu-like symptoms almost immediately upon dosing. Despite that, one patient called the side effects “trivial,” compared to other treatments they’d received, according to Russell.
     
    William Phelps, Director of the Preclinical and Translational Cancer Research Program at the American Cancer Society, said the study is exciting because it shows efficacy with humans.
     
    “Viruses are very good at disseminating throughout the body,” he said, adding that they’re also adept at hunting, detecting and infecting metastatic tumors.
     
    Another advantage of using viruses is that they’re mutable, said Phelps.
     
    “We can make a lot of changes to change what cells they infect,” he said. “We can change their payloads to specifically kill cancer.”
     
    According to an editorial accompanying the paper, Dr. John C. Bell of the Centre for Innovative Cancer Research in Ottawa, Canada, described the findings as a “benchmark to strive for and improve upon.”
     
    When asked if the study had implications for other types of cancer, Russell answered with an emphatic yes.
     
    “There’s no real reason why it can’t work on other cancers,” said Bell, adding that cancer provides the “perfect substrate” for viruses because they’re metabolically active, fast growing and, “don’t know how to turn off.
     
    “Once the virus gets in there, it can just move,” he said. “There are a lot of reasons they’re happier growing in cancer.”
     
    More trials are planned.
     
    “We want to take this virus and test it much more efficiently in a larger group to determine how often it works,” said Russell.
     
    According to the Mayo Clinic, more of the MV-NIS therapy is being manufactured for a larger, phase 2 clinical trial later this year.
     
    Phelps said his one concern about the study was that the two patients did not have any antibodies for measles, making them very rare because most people have been vaccinated against or had the measles.
     
    One possible next step is “trying to engineer the virus so that it wouldn’t be neutralized by your antibodies," said Phelps. “Intuitively, you should be able to do that."
     
    Russell believes that what this study has proved is valuable and can be built upon.
     
    “We recently have begun to think about the idea of a single shot cure for cancer, and that’s our goal with this therapy,” he said.

    The findings appear in the peer-reviewed journal Mayo Clinic Proceedings.

    Here's a video about the treatment:
     

    You May Like

    Syrian Torture Victim Recounts Horrors

    'You make them think you have surrendered' says Jalal Nofal, a doctor who was jailed and survived repeated interrogations in Syria

    Mandela’s Millions Paid to Heirs, But Who Gets His Country Home?

    Saga around $3 million estate of country's first democratic president is far from over as Winnie Mandela’s fight for home overshadows payouts

    Guess Which Beach is 'Best in the US'?

    Hawaii’s Hanauma Bay tops an annual "top 10" list compiled by a coastal scientist, also known as Doctor Beach

    This forum has been closed.
    Comment Sorting
    Comments
         
    by: MOD from: china
    May 18, 2014 8:21 AM
    Hope it's useful and THX~!

    by: Dr. Livkin from: UK
    May 17, 2014 9:01 PM
    However, there is POISON in the flu vaccine=MERCURY, a deadly neurotoxin that is NOT to be introduced into the human body unless of course, you want to invite cognitive disorders and cancer. FACTS AND RESEARCH WILL DICTATE THAT.

    by: kanapathy pillai yogaraaj from: srilanka
    May 17, 2014 5:05 AM
    we support civilrights-Like

    by: jom from: china
    May 16, 2014 3:31 PM
    Thank you for this hopeful article

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Chinese-Americans Heart Trump, Bucking National Trendi
    X
    May 27, 2016 5:57 AM
    A new study conducted by three Asian-American organizations shows there are three times as many Democrats as there are Republicans among Asian-American voters, and they favor Hillary Clinton over Donald Trump. But one group, called Chinese-Americans For Trump, is going against the tide and strongly supports the business tycoon. VOA’s Elizabeth Lee caught up with them at a Trump rally and reports from Anaheim, California.
    Video

    Video Chinese-Americans Heart Trump, Bucking National Trend

    A new study conducted by three Asian-American organizations shows there are three times as many Democrats as there are Republicans among Asian-American voters, and they favor Hillary Clinton over Donald Trump. But one group, called Chinese-Americans For Trump, is going against the tide and strongly supports the business tycoon. VOA’s Elizabeth Lee caught up with them at a Trump rally and reports from Anaheim, California.
    Video

    Video Reactions to Trump's Success Polarized Abroad

    What seemed impossible less than a year ago is now almost a certainty. New York real estate mogul Donald Trump has won the number of delegates needed to secure the Republican presidential nomination. The prospect has sparked as much controversy abroad as it has in the United States. Zlatica Hoke has more.
    Video

    Video Drawings by Children in Hiroshima Show Hope and Peace

    On Friday, President Barack Obama will visit Hiroshima, Japan, the first American president to do so while in office. In August 1945, the United States dropped an atomic bomb on the city to force Japan's surrender in World War II. Although their city lay in ruins, some Hiroshima schoolchildren drew pictures of hope and peace. The former students and their drawings are now part of a documentary called “Pictures from a Hiroshima Schoolyard.” VOA's Deborah Block has the story.
    Video

    Video Vietnamese Rapper Performs for Obama

    A prominent young Vietnamese artist told President Obama said she faced roadblocks as a woman rapper, and asked the president about government support for the arts. He asked her to rap, and he even offered to provide a base beat for her. Watch what happened.
    Video

    Video Roots Run Deep for Tunisia's Dwindling Jewish Community

    This week, hundreds of Jewish pilgrims are defying terrorist threats to celebrate an ancient religious festival on the Tunisian island of Djerba. The festivities cast a spotlight on North Africa's once-vibrant Jewish population that has all but died out in recent decades. Despite rising threats of militant Islam and the country's battered economy, one of the Arab world's last Jewish communities is staying put and nurturing a new generation. VOA’s Lisa Bryant reports.
    Video

    Video Meet Your New Co-Worker: The Robot

    Increasing numbers of robots are joining the workforce, as companies scale back and more processes become automated. The latest robots are flexible and collaborative, built to work alongside humans as opposed to replacing them. VOA’s Tina Trinh looks at the next generation of automated employees helping out their human colleagues.
    Video

    Video Wheelchair Technology in Tune With Times

    Technologies for the disabled, including wheelchair technology, are advancing just as quickly as everything else in the digital age. Two new advances in wheelchairs offer improved control and a more comfortable fit. VOA's George Putic reports.
    Video

    Video Baby Boxes Offer Safe Haven for Unwanted Children

    No one knows exactly how many babies are abandoned worldwide each year. The statistic is a difficult one to determine because it is illegal in most places. Therefore unwanted babies are often hidden and left to die. But as Erika Celeste reports from Woodburn, Indiana, a new program hopes to make surrendering infants safer for everyone.
    Video

    Video California Celebration Showcases Local Wines, Balloons

    Communities in the U.S. often hold festivals to show what makes them special. In California, for example, farmers near Fresno celebrate their figs and those around Gilmore showcase their garlic. Mike O'Sullivan reports that the wine-producing region of Temecula offers local vintages in an annual festival where rides on hot-air balloons add to the excitement.
    Video

    Video US Elementary School Offers Living Science Lessons

    Zero is not a good score on a test at school. But Discovery Elementary is proud of its “net zero” rating. Net zero describes a building in which the amount of energy provided by on-site renewable sources equals the amount of energy the building uses. As Faiza Elmasry tells us, the innovative features in the building turn the school into a teaching tool, where kids can't help but learn about science and sustainability. Faith Lapidus narrates.

    Special Report

    Adrift The Invisible African Diaspora